A unique function for LRP-1: a component of a two-receptor system mediating specific endocytosis of plasma-derived factor V by megakaryocytes

被引:25
作者
Bouchard, B. A. [1 ]
Meisler, N. T. [1 ]
Nesheim, M. E. [2 ]
Liu, C. -X. [3 ]
Strickland, D. K. [3 ]
Tracy, P. B. [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA
[2] Queens Univ, Dept Biochem & Med, Kingston, ON, Canada
[3] Univ Maryland, Sch Med, Dept Surg & Physiol, Baltimore, MD 21201 USA
关键词
endocytosis; factor V; LRP-1; megakaryocytes;
D O I
10.1111/j.1538-7836.2008.02894.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Factor V is endocytosed by megakaryocytes from plasma via a specific, receptor-mediated, clathrin-dependent mechanism to form the unique platelet-derived FV pool. Objective: The role of low-density lipoprotein (LDL) receptor-related protein-1 (LRP-1), or a related family member, in FV endocytosis by megakaryocytes was examined because of its known interactions with other proteins involved in hemostasis. Methods: LRP-1 expression by megakaryocytes and its functional role in FV endocytosis was confirmed using reverse transcription polymerase chain reaction (RT-PCR) and specific antibodies. FV binding to megakaryocytes was performed under Ca2+-free conditions to quantify binding in the absence of endocytosis. Results and conclusion: Cell surface expression of LRP-1 by CD34+ ex vivo-derived megakaryocytes and the megakaryocyte-like cell line CMK was confirmed using anti-LRP-1 antibodies and was consistent with the detection of LRP-1 message in these cells. All cells capable of endocytosing FV expressed LRP-1. Anti-LRP-1 antibodies and receptor-associated protein (RAP), a known antagonist of LDL receptor family members, displaced only 50% of the [I-125]FV bound to megakaryocytes. FV binding to megakaryocytes showed positive cooperativity (Hill coefficient = 1.92 +/- 0.18) that was substantially reduced in the presence of RAP (1.47 +/- 0.26). As FV endocytosis is specific to this cofactor, a model is hypothesized where FV binding to a specific receptor facilitates binding and endocytosis of a second FV molecule by LRP-1, or a related family member. These combined observations describe a unique role for LRP-1 in endocytosis of a coagulation protein trafficked to alpha-granules and not destined for lysosomal degradation.
引用
收藏
页码:638 / 644
页数:7
相关论文
共 36 条
[1]  
BARMINA OY, 1999, J BIOL CHEM, V274
[2]   Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event [J].
Bouchard, BA ;
Williams, JL ;
Meisler, NT ;
Long, MW ;
Tracy, PB .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (03) :541-551
[3]   Subsequent to its endocytosis by megakaryocytes, factor V is trafficked to the cis-golgi network prior to its storage in α-granules. [J].
Bouchard, Beth A. ;
Taatjes, Douglas J. ;
Meisler, Natalie T. ;
Tracy, Paula B. .
BLOOD, 2006, 108 (11) :483A-483A
[4]   THE MECHANISM OF INACTIVATION OF HUMAN PLATELET FACTOR VA FROM NORMAL AND ACTIVATED PROTEIN C-RESISTANT INDIVIDUALS [J].
CAMIRE, RM ;
KALAFATIS, M ;
CUSHMAN, M ;
TRACY, RP ;
MANN, KG ;
TRACY, PB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) :20794-20800
[5]   Platelet-derived factor Va/VaLeiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C [J].
Camire, RM ;
Kalafatis, M ;
Simioni, P ;
Girolami, A ;
Tracy, PB .
BLOOD, 1998, 91 (08) :2818-2829
[6]  
Conlon S.J., 1997, THROMB HAEMOSTASIS, V77, p2507a
[7]   Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins [J].
Czekay, RP ;
Aertgeerts, K ;
Curriden, SA ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 2003, 160 (05) :781-791
[8]   Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity [J].
Czekay, RP ;
Kuemmel, TA ;
Orlando, RA ;
Farquhar, MG .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (05) :1467-1479
[9]   Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet derived cofactor [J].
Gould, WR ;
Simioni, P ;
Silveira, JR ;
Tormene, D ;
Kalafatis, M ;
Tracy, PB .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (03) :450-456
[10]   Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor -: Characterization of purified platelet-derived factor V/Va [J].
Gould, WR ;
Silveira, JR ;
Tracy, PB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (04) :2383-2393